In a significant step toward eliminating hepatitis B transmission, Ghana Health Service has announced that the Hepatitis B Birth Dose vaccine will be incorporated into the country’s national routine immunization schedule starting in the fourth quarter of 2025.

This strategic move aims to curb mother-to-child transmission of hepatitis B, a major public health challenge. Health officials emphasize that administering the vaccine within 24 hours of birth—or at the latest, within the first two weeks—can prevent up to 90% of infections passed from mothers to their newborns.

Dr. Oliver Commey, Director for Infectious Diseases, speaking on behalf of the Director-General, highlighted the milestone as a testament to the resilience of Ghana's health systems. He stressed that the new vaccine introduction aligns with World Health Organization (WHO) recommendations and continues the nation’s commitment to immunization, following the successful rollout of the pentavalent vaccine in 2002.

"The strength of our Expanded Programme on Immunization (EPI) and the unwavering support from our partners are making it possible to protect every newborn from day one," Dr. Commey stated.

The introduction of the birth dose vaccine marks a vital step toward reducing hepatitis B prevalence in the country and safeguarding the health of future generations.

Credit: Ghana Health Service